As of April 19, 2025, Sera Prognostics (SERA) has a market cap of $0.13 billion USD. According to our data, Sera Prognostics is ranked No.7379 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $0.13 B |
-52.04%
|
Dec 31, 2024 | $0.27 B |
36.12%
|
Dec 29, 2023 | $0.20 B |
374.60%
|
Dec 30, 2022 | $41.33 M |
-81.66%
|
Dec 31, 2021 | $0.23 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Natera
NTRA
|
$20.02 B |
0.001 M
|
![]() USA
|
![]() Myriad Genetics
MYGN
|
$0.70 B |
0.000 M
|
![]() USA
|
![]() Guardant Health
GH
|
$5.55 B |
-0.000 M
|
![]() USA
|
![]() Exact Sciences
EXAS
|
$7.72 B |
-0.000 M
|
![]() USA
|
![]() Illumina
ILMN
|
$11.27 B |
-0.000 M
|
![]() USA
|
![]() NeoGenomics
NEO
|
$1.23 B |
0.000 M
|
![]() USA
|
![]() Fulgent Genetics
FLGT
|
$0.55 B |
0.000 M
|
![]() USA
|
![]() CareDx
CDNA
|
$0.98 B |
0.000 M
|
![]() USA
|
![]() Veracyte
VCYT
|
$2.43 B |
0.000 M
|
![]() USA
|
![]() Adaptive Biotechnologies
ADPT
|
$1.09 B |
0.000 M
|
![]() USA
|
![]() Pacific Biosciences
PACB
|
$0.35 B |
-0.000 M
|
![]() USA
|
![]() 10x Genomics
TXG
|
$0.92 B |
0.103 B
|
![]() USA
|
Market Cap | = | SERA Stock Price | * | SERA Shares Outstanding |
= | $3.40 | * | 36.70 M | |
= | $0.13 B |